ChitogenX Inc.
CHNXF · OTC
1/31/2024 | 1/31/2023 | 1/31/2022 | 1/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | 0.24 | -0.24 | -0.17 |
| FCF Yield | -16.33% | -30.18% | -35.81% | -15.84% |
| EV / EBITDA | -3.72 | -3.45 | -4.54 | -8.29 |
| Quality | ||||
| ROIC | 132.30% | 149.01% | -1,867.55% | -98.08% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.65 | 0.51 | 0.65 | 0.79 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 68.44% | 1.72% | -9.01% | -87.55% |
| Safety | ||||
| Net Debt / EBITDA | -1.43 | -1.17 | -1.69 | -0.88 |
| Interest Coverage | -3.36 | -3.48 | -2.95 | -3.30 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -19,040.83 | -9,180.68 | -2,465.07 | -988.37 |